Is Cystoscopic Intravesical Injection of OnabotulinumtoxinA Acceptable in an Outpatient Clinic?
Cystoscopic intravesical injection of onabotulinumtoxinA appears more painful than diagnostic cystoscopy. However, as VAS scores were relatively low, this is unlikely to represent clinically significant discomfort burdensome to the patient. There were no significant complications postprocedure. Cystoscopic intravesical onabotulinumtoxinA injection is acceptable in an outpatient setting.
Authors
- Ilias Giarenis (ORCID: https://orcid.org/0000-0002-7644-9010)
- Thomas James Curtis (ORCID: https://orcid.org/0000-0002-6942-0615)
- Thomas Gray (ORCID: https://orcid.org/0000-0001-7719-4366)
- Michelle Drolet
Institutions
- University of East Anglia (GB)
- Norfolk and Norwich University Hospitals NHS Foundation Trust (GB)
Publication Details
- Journal
- International Neurourology Journal
- Published
- 2025-03-28
- DOI
- https://doi.org/10.5213/inj.2448392.196
- Citations
- 1
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 1.84